Advances in Systemic Therapy in Pancreatic Cancer

HY Kenneth - Hematology/Oncology Clinics, 2024 - hemonc.theclinics.com
Pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancer mortality in
the US, with an estimated 60,050 new cases diagnosed and 50,550 deaths in 2023. 1 Due …
相关文章

Advances in Systemic Therapy in Pancreatic Cancer.

KH Yu - Hematology/oncology Clinics of North America, 2024 - europepmc.org
Substantial progress has been made toward understanding biology and developing new
therapies for pancreatic ductal adenocarcinoma (PDAC). In this review, new insights from …

Advances in Systemic Therapy in Pancreatic Cancer

HY Kenneth - Hematology/oncology clinics of North America - pubmed.ncbi.nlm.nih.gov
Substantial progress has been made toward understanding biology and developing new
therapies for pancreatic ductal adenocarcinoma (PDAC). In this review, new insights from …